Trial intelligence / Profile preview

MK0719 for postoperative dental pain

NCT00424424Phase 2Terminated

Sponsor
Merck & Co.
Start
Aug 2006
Primary completion
Jan 2007
Modality
Small Molecules
01

Overview

A Phase 2 trial of MK-0719 in odontalgia, sponsored by Merck & Co.. Started Aug 2006; status: terminated.

02

Drugs

MK-0719
03

Conditions

odontalgia

Beyond the preview

Go deeper on NCT00424424.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00424424.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call